Edition:
United Kingdom

PW Medtech Group Ltd (1358.HK)

1358.HK on Hong Kong Stock

1.40HKD
7:10am BST
Change (% chg)

HK$-0.02 (-1.41%)
Prev Close
HK$1.42
Open
HK$1.41
Day's High
HK$1.43
Day's Low
HK$1.40
Volume
188,000
Avg. Vol
1,123,431
52-wk High
HK$1.89
52-wk Low
HK$1.24

Latest Key Developments (Source: Significant Developments)

PW Medtech Group Enters Into Loan Agreement For Loan Of $82.7 MLn
Thursday, 20 Sep 2018 

Sept 21 (Reuters) - PW Medtech Group Ltd <1358.HK>::ENTERED INTO A LOAN AGREEMENT FOR LOAN OF $82.7 MILLION.  Full Article

PW Medtech Group Posts HY Profit Attributable Of RMB1.59 Bln
Wednesday, 29 Aug 2018 

Aug 29 (Reuters) - PW Medtech Group Ltd <1358.HK>::HY PROFIT ATTRIBUTABLE RMB1,587.8 MILLION VERSUS RMB81.7 MILLION.HY REVENUE FROM CONTINUING OPERATIONS RMB143.0 MILLION, UP 9.8%.  Full Article

PW Medtech Group To Purchase 800,000 China Biologic Products Shares For $80.72 Mln
Friday, 24 Aug 2018 

Aug 24 (Reuters) - PW Medtech Group Ltd <1358.HK>::CO TO PURCHASE 800,000 CHINA BIOLOGIC PRODUCTS (CBPO) SHARES, AT A PRICE OF US$100.9 PER CBPO SHARE.AGGREGATE PURCHASE PRICE FOR CBPO SHARES SHALL BE $80.72 MILLION.  Full Article

China Biologic agrees to acquire Tianxinfu from PWM
Thursday, 12 Oct 2017 

Oct 12 (Reuters) - China Biologic Products Holdings Inc :China Biologic agrees to acquire Tianxinfu from PWM.China Biologic Products Holdings Inc - ‍It has agreed to acquire 80% equity interest in Tianxinfu (Beijing) Medical Appliance Co., Ltd​.China Biologic Products - ‍In exchange for acquisition of 80% equity interest in Tianxinfu from PWM, Cbpo will issue 5.5 million ordinary shares to PWM​.China Biologic Products - ‍PWM is expected to hold approximately 16.66% of outstanding share capital of Cbpo taking into effect new issuance​ post deal.China Biologic Products - Board determined to exempt deal from causing PWM to be deemed "acquiring person" under CBPO's preferred shares rights agreement​.China Biologic Products Holdings Inc - ‍Acquire 80% equity interest in Tianxinfu from PW Medtech Group Limited​.China Biologic Products - ‍CBPO elected to be exempted from shareholder approval requirement under applicable rules of nasdaq market for proposed deal.China Biologic Products Holdings - ‍Elected to be exempted from shareholder approval requirement under applicable rules of Nasdaq stock market for deal.China Biologic Products Holdings Inc - ‍Post deal close, PWM expected to hold about 16.66% of share capital of co taking into effect new issuance​.  Full Article

PW Medtech Group says co & CBPO entered into share exchange agreement​
Thursday, 12 Oct 2017 

Oct 12 (Reuters) - PW Medtech Group Ltd <1358.HK>:Co & CBPO entered into share exchange agreement​.Acquisition & disposal relating to proposed subscription for CBPO shares in consideration of disposal business​.Deal for consideration of about US$513.45 million​.  Full Article

PW Medtech Group proposes a possible spin-off
Monday, 24 Jul 2017 

July 24 (Reuters) - PW Medtech Group Ltd <1358.HK>::Proposes a possible spin-off and separate listing of spin-off company on a share stock exchange.Expected that upon completion of proposed spin-off & proposed a shares issuance, co will have interest of not less than 68 pct in spin-off co.No formal application for proposed spin-off and proposed a shares issuance has been filed with relevant regulatory authorities in PRC.  Full Article